PDGFRB and neoplasm: The strong positive correlation between serum CST4 levels and PDGFRB expression (Spearman’s rho=0.42, P<0.001) suggests a coordinated regulatory mechanism that may drive extracellular matrix (ECM) remodeling and tumor vascularization.